Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 179,783 | 184,356 | 184,295 | 188,237 | 190,559 |
| Cost of Goods | 86,345 | 89,578 | 92,083 | 92,091 | 96,919 |
| Gross Profit | 93,438 | 94,778 | 92,212 | 96,146 | 93,640 |
| Operating Expenses | 67,440 | 62,976 | 63,132 | 69,138 | 202,315 |
| Operating Income | 26,343 | 32,380 | 29,163 | 27,099 | -107,756 |
| Interest Expense | 15,016 | 13,813 | 14,071 | 14,331 | 11,764 |
| Other Income | -5 | -59,508 | 856 | 50 | 329 |
| Pre-tax Income | 11,322 | -40,941 | 15,948 | 12,818 | -119,191 |
| Income Tax | 19,016 | 10,238 | 18,003 | 7,950 | -5,746 |
| Net Income Continuous | -7,694 | -51,179 | -2,055 | 4,868 | -113,445 |
| Minority Interests | 2,847 | 3,153 | 3,138 | 2,233 | 2,127 |
| Net Income | $-10,541 | $-54,332 | $-5,193 | $2,635 | $-115,572 |
| EPS Basic Total Ops | -0.03 | -0.16 | -0.02 | 0.01 | -0.34 |
| EPS Basic Continuous Ops | -0.02 | -0.15 | -0.01 | 0.01 | -0.34 |
| EPS Diluted Total Ops | -0.03 | -0.16 | -0.02 | 0.01 | -0.34 |
| EPS Diluted Continuous Ops | -0.02 | -0.15 | -0.01 | 0.01 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.16 | -0.02 | 0.01 | -0.04 |
| EBITDA(a) | $42,963 | $48,822 | $46,458 | $49,056 | $-90,751 |